News in brief: Combination therapy may overcome resistant AML; Stonefish venom causes anticoagulation; Lifeblood rethink on UK blood donor ban

New combination may overcome AML resistance Researchers at the Walter and Eliza Hall Institute (WEHI) have discovered why some leukaemia cells are resistant to new ‘SMAC-mimetic’ anti-cancer agents such as birinapant, a finding that could lead to combination therapy that would overcome drug resistance. The team showed that the ‘drug pump’ protein MDR1 makes acute ...

Already a member?

Login to keep reading.

© 2021 the limbic